Showing 8701-8720 of 8730 for: Cochrane Systematic Reviews Back
- Yoga treatment for chronic non‐specific low back pain
Cochrane Systematic Reviews, 12-Jan-2017
Non-specific low back pain is a common, potentially disabling condition usually treated with self-care and non-prescription medication. For chronic low back pain, current guidelines state that exercise therapy may be beneficial. Yoga is a mind-body exerci
- Yoga versus non‐standard care for schizophrenia
Cochrane Systematic Reviews, 28-Sep-2017
Yoga is an ancient spiritual practice that originated in India and is currently accepted in the Western world as a form of relaxation and exercise. It has been of interest for people with schizophrenia as an alternative or adjunctive treatment.
- Yoga versus standard care for schizophrenia
Cochrane Systematic Reviews, 21-Oct-2015
Yoga is an ancient spiritual practice that originated in India and is currently accepted in the Western world as a form of relaxation and exercise. It has been of interest for people with schizophrenia to determine its efficacy as an adjunct to standard-c
- Yttrium‐90 microsphere radioembolisation for unresectable hepatocellular carcinoma
Cochrane Systematic Reviews, 16-Nov-2020
- Zhiling decoction for vascular dementia
Cochrane Systematic Reviews, 5-May-2008
Zhiling decoction has a fixed composition of 15 Chinese herbs. The properties of each of these herbs and in combination provide the therapeutic rationale for a possible action of Zhiling decoction in dilating cerebral vessels and increasing cerebral blood
- Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults
Cochrane Systematic Reviews, 24-Jul-2000
Zidovudine (AZT) monotherapy was the first antiretroviral drug to be tested widely. The next two drugs to be developed were didanosine (ddI) and zalcitabine (ddC).
- Zinc for the common cold
Cochrane Systematic Reviews, 17-Sep-2016
The common cold is one of the most widespread illnesses and is a leading cause of visits to the doctor and absence from school and work. Trials conducted in high-income countries since 1984 investigating the role of zinc for the common cold symptoms have
- Zinc supplementation as an adjunct to antibiotics in the treatment of pneumonia in children 2 to 59 months of age
Cochrane Systematic Reviews, 5-Oct-2011
Diarrhoeal disorders and acute respiratory infections (ARIs), especially pneumonia, are the most common causes of death in low-income countries. Studies evaluating the impact of zinc supplementation as an adjunct in the management of pneumonia are limited
- Zinc supplementation for improving pregnancy and infant outcome
Cochrane Systematic Reviews, 16-Mar-2021
It has been suggested that low serum zinc levels may be associated with suboptimal outcomes of pregnancy, such as prolonged labour, atonic postpartum haemorrhage, pregnancy-induced hypertension, preterm labour and post-term pregnancies, although these ass
- Zinc supplementation for mental and motor development in children
Cochrane Systematic Reviews, 13-Nov-2012
Zinc deficiency is a significant public health problem in low- and middle-income countries. Zinc is essential for the formation and migration of neurons along with the formation of neuronal synapses. Its deficiency could interfere with the formation of ne
- Zinc supplementation for preventing mortality, morbidity, and growth failure in children aged 6 months to 12 years of age
Cochrane Systematic Reviews, 1-May-2014
Zinc deficiency is prevalent in low- and middle-income countries, and contributes to significant diarrhoea-, pneumonia-, and malaria-related morbidity and mortality among young children. Zinc deficiency also impairs growth.
- Zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months
Cochrane Systematic Reviews, 4-Dec-2016
Pneumonia is a leading cause of morbidity and mortality in children younger than five years of age. Most deaths occur during infancy and in low-income countries. Daily zinc supplements have been reported to prevent acute lower respiratory tract infection
- Zinc supplementation for the prevention of type 2 diabetes mellitus in adults with insulin resistance
Cochrane Systematic Reviews, 28-May-2015
Diabetes is associated with long-term damage, dysfunction and failure of various organs, especially the eyes, kidneys, nerves, heart and blood vessels. The risk of developing type 2 diabetes increases with age, obesity and lack of physical activity. Insul
- Zinc supplementation for the promotion of growth and prevention of infections in infants less than six months of age
Cochrane Systematic Reviews, 8-Apr-2020
Zinc is a vital micronutrient for humans and is essential for protein synthesis, cell growth, and differentiation. Severe zinc deficiency can lead to slower physical, cognitive and sexual growth, cause skin disorders, decrease immunity, increase incidence
- Zinc supplementation for the treatment of measles in children
Cochrane Systematic Reviews, 20-Jun-2017
Measles is an important cause of childhood morbidity and mortality globally, despite increasing vaccine coverage. Zinc plays a significant role in the maintenance of normal immunological functions, therefore supplements given to zinc-deficient children wi
- Zinc supplementation for tinnitus
Cochrane Systematic Reviews, 23-Nov-2016
Tinnitus is the perception of sound without external acoustic stimuli. Patients with severe tinnitus may have physical and psychological complaints and their tinnitus can cause deterioration in their quality of life. At present no specific therapy for tin
- Zinc supplements for preventing otitis media
Cochrane Systematic Reviews, 29-Jun-2014
Otitis media is inflammation of the middle ear and is usually caused by infection. It affects people of all ages but is particularly common in young children. Around 164 million people worldwide have long-term hearing loss caused by this condition, 90% of
- Zinc supplements for treating thalassaemia and sickle cell disease
Cochrane Systematic Reviews, 26-Jun-2013
Haemoglobinopathies, inherited disorders of haemoglobin synthesis (thalassaemia) or structure (sickle cell disease), are responsible for significant morbidity and mortality throughout the world. The WHO estimates that, globally, 5% of adults are carriers
- Ziprasidone for schizophrenia and severe mental illness
Cochrane Systematic Reviews, 18-Jan-2012
Typical antipsychotic drugs are widely used as the first line treatment for people with schizophrenia. However, the atypical class of antipsychotic drugs are making important inroads into this approach. Atypical is a widely used term used to describe some
- Ziprasidone versus other atypical antipsychotics for schizophrenia
Cochrane Systematic Reviews, 7-Oct-2009
In many countries of the industrialised world second generation ('atypical') antipsychotics have become the first line drug treatment for people with schizophrenia. The question as to whether, and if so how much, the effects of the various new generation
